
FDA panel reviews BPC-157 and TB-500 compounds July 23-24, and telehealth is bracing
If compounding wellness peptides goes legal, the next multibillion-dollar telehealth play could shift from gray-market supply to licensed channels.
By Hessa Al-Faleh·· 4 min


